Prior COVID-19 significantly reduces the risk of subsequent infection, but reinfections are seen after eight months
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Microbiology (medical)
Reference10 articles.
1. Hanrath AT, Payne BAI, Duncan CJA. Prior SARS-CoV-2infection is associated with protection against symptomatic reinfection. J Infect (2020 Dec 23), doi:10.1016/j.jinf.2020.12.023.
2. Lumley SF, O'Donnell D, Stoesser NE, Matthews PC, Howarth A, Hatch SB, et al. Antibody status and incidence of SARS-CoV-2 infection in health care workers. N Engl J Med. (2020 Dec 23), doi:10.1056/NEJMoa2034545. Epub ahead of print. PMID: 33369366.
3. Lessons for COVID-19 immunity from other coronavirus infections;Sariol;Immunity,2020
4. Tan Y, Liu F, Xu X, Ling Y, Huang W, Zhu Z, et al. Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection. Front Med 2020 Sep 16. [Epub ahead of print] doi:10.1007/s11684-020-0822-5.
5. Genomic evidence for reinfection with SARS-CoV-2: a case study;Tillett;Lancet Infect Dis,2021
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Investigation of epidemiological and clinical characteristics of people infected with SARS-CoV-2 during the second pandemic of COVID-19 in Chengdu, China;Frontiers in Public Health;2024-05-01
2. Humoral and Cellular Immune Response after Three Doses of Sinopharm [Vero Cell]-Inactivated COVID-19 Vaccine in Combination with SARS-CoV-2 Infection Leads to Hybrid Immunity;Pharmaceuticals;2024-01-17
3. Virus-like particles (VLPs)-based vaccines against COVID-19: Where do we stand amid the ongoing evolution of SARS-CoV-2?;Health Sciences Review;2023-12
4. Effectiveness of various COVID-19 vaccine regimens among 10.4 million patients from the National COVID Cohort Collaborative during Pre-Delta to Omicron periods – United States, 11 December 2020 to 30 June 2022;Vaccine;2023-10
5. Evaluation of possible COVID-19 reinfection in children: A multicenter clinical study;Archives de Pédiatrie;2023-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3